MoneyWorks4Me

Wanbury - Quaterly Results

12 Aug 2024 Evaluate
The sales declined to Rs. 1311.08 millions for the June 2024 quarter as compared to Rs. 1462.85 millions during the corresponding quarter last year.A radical decline of -77.88% was reported in the net profit of the company for the quarter ended June 2024 to Rs. 10.37  millions from Rs. 46.89 millions.A decline of 119.19 millions was observed in the OP in the quarter ended June 2024 from 139.65 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1311.08 1462.85 -10.37 1311.08 1462.85 -10.37 5756.50 4996.47 15.21
Other Income 9.45 6.17 53.16 9.45 6.17 53.16 29.90 9.13 227.49
PBIDT 119.19 139.65 -14.65 119.19 139.65 -14.65 729.93 240.85 203.06
Interest 75.93 57.89 31.16 75.93 57.89 31.16 291.81 213.94 36.40
PBDT 43.26 81.76 -47.09 43.26 81.76 -47.09 438.12 20.97 1989.27
Depreciation 32.89 31.85 3.27 32.89 31.85 3.27 130.31 123.85 5.22
PBT 10.37 49.91 -79.22 10.37 49.91 -79.22 307.81 -102.88 -399.19
TAX 0.00 3.02 0.00 0.00 3.02 0.00 3.81 1.09 249.54
Deferred Tax 0.00 3.02 0.00 0.00 3.02 0.00 3.81 1.09 249.54
PAT 10.37 46.89 -77.88 10.37 46.89 -77.88 304.00 -103.97 -392.39
Equity 327.46 327.06 0.12 327.46 327.06 0.12 327.46 327.06 0.12
PBIDTM(%) 9.09 9.55 -4.77 9.09 9.55 -4.77 12.68 4.82 163.05
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..